Following its recent clearance in Europe , ACE-031 1mg is facing notable uptake. Sales figures indicate a increasing response among healthcare professionals , particularly in Germany . Obstacles surrounding reimbursement remain, and are currently being managed by the developer through continued negotiations with payers . The initial market projecti